NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

MysmA.01530.c: Enoyl-CoA hydratase

Target Characteristics

from organism: Mycobacterium smegmatis ATCC 700084 / mc(2)155
most recent status: diffraction
center reference id: MysmA.01530.c
is community request: False
associated disease:
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
IIIC

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.01530.c.A1.GE28942 Full length( MysmA.01530.c ) 1 266 GE28942
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

Proteins

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
MysmA.01530.c.A1.PS00771 Full length( MysmA.01530.c ) 1 266
MysmA.01530.c.A1.PW30072 Full length( MysmA.01530.c ) 1 266

External Resources

Resource Reference ID
OrthoMCL: OG5_169926
PATRIC ID: fig|246196.19.peg.5755
RefSeq: YP_890141.1
UniProt: A0R4Q3

Enzyme & Pathway Information

Pathway Pathway ID EC Number
fatty acid beta-oxidation I FAO-PWY 4.2.1.17
L-isoleucine degradation I ILEUDEG-PWY 4.2.1.17
oleate beta-oxidation PWY0-1337 4.2.1.17
phenylacetate degradation I (aerobic) PWY0-321 4.2.1.17
benzoyl-CoA degradation I (aerobic) PWY-1361 4.2.1.17
fermentation to 2-methylbutanoate PWY-5109 4.2.1.17
fatty acid beta-oxidation II (peroxisome) PWY-5136 4.2.1.17
unsaturated, even numbered fatty acid beta-oxidation PWY-5138 4.2.1.17
superpathway of glyoxylate cycle and fatty acid degradation PWY-561 4.2.1.17
superpathway of phenylethylamine degradation PWY-6071 4.2.1.17
4-hydroxybenzoate biosynthesis III (plants) PWY-6435 4.2.1.17
fatty acid beta-oxidation VI (peroxisome) PWY66-391 4.2.1.17
pyruvate fermentation to hexanol (engineered) PWY-6863 4.2.1.17
superpathway of cholesterol degradation I (cholesterol oxidase) PWY-6928 4.2.1.17
superpathway of testosterone and androsterone degradation PWY-6937 4.2.1.17
androstenedione degradation PWY-6944 4.2.1.17
superpathway of cholesterol degradation II (cholesterol dehydrogenase) PWY-6947 4.2.1.17
methyl ketone biosynthesis (engineered) PWY-7007 4.2.1.17
4-coumarate degradation (anaerobic) PWY-7046 4.2.1.17
fatty acid salvage PWY-7094 4.2.1.17
jasmonic acid biosynthesis PWY-735 4.2.1.17
docosahexaenoate biosynthesis III (6-desaturase, mammals) PWY-7606 4.2.1.17
(8E,10E)-dodeca-8,10-dienol biosynthesis PWY-7654 4.2.1.17
Spodoptera littoralis pheromone biosynthesis PWY-7656 4.2.1.17
(4Z,7Z,10Z,13Z,16Z)-docosapentaenoate biosynthesis (6-desaturase) PWY-7726 4.2.1.17
toluene degradation to benzoyl-CoA (anaerobic) PWY-81 4.2.1.17
L-valine degradation I VALDEG-PWY 4.2.1.17

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MSETGKGPDA LVEQRGHTLI VTLNRPEARN ALSGEMLSIM VEAWDRVDND PEIRTCILTG AGGYFCSGMD LKGADKKPPG DSFKDGSYDP SKIPGLLKGR RLTKPLIAAV EGPAIAGGTE ILQGTDIRVA GESAKFGISE AKWSLYPMGG SAVRLVRQIP YTIACDMLLT GRHITAAEAK EYGLIGYVVP DGTALDKALE IAETINNNGP LAVQAILKTI RETEGMHEDE AFGPDTRNGI PVFLSEDAKE GPRAFKEKRA PNFQMK

NT Sequence
GTGAGTGAGA CCGGCAAGGG GCCTGACGCC CTCGTTGAGC AGCGCGGACA CACCCTCATC GTCACGTTGA ACCGTCCTGA GGCGCGCAAC GCTCTCTCGG GCGAGATGCT CTCGATCATG GTCGAAGCAT GGGACCGGGT CGACAACGAT CCGGAGATCC GCACCTGCAT CCTGACCGGC GCCGGCGGTT ACTTCTGCTC GGGCATGGAC CTCAAGGGCG CGGACAAGAA GCCGCCGGGT GACTCGTTCA AGGACGGCAG CTACGACCCG TCGAAGATTC CAGGCCTGCT CAAGGGCCGC CGTCTGACCA AGCCGCTGAT CGCCGCGGTC GAGGGTCCCG CCATCGCGGG CGGCACCGAG ATCCTGCAGG GCACCGACAT CCGCGTGGCC GGTGAGAGCG CCAAGTTCGG GATCTCCGAG GCCAAGTGGA GCCTGTACCC GATGGGCGGT TCGGCCGTGC GCCTGGTGCG CCAGATCCCC TACACCATCG CGTGCGACAT GCTGCTCACC GGTCGCCACA TCACCGCGGC CGAGGCCAAG GAGTACGGCC TGATCGGGTA CGTCGTTCCC GACGGCACCG CGCTGGACAA GGCGCTGGAG ATCGCCGAGA CCATCAACAA CAACGGTCCG CTCGCCGTGC AGGCGATCCT CAAGACCATC CGTGAGACCG AGGGCATGCA CGAGGACGAG GCGTTCGGCC CCGACACCCG CAACGGCATC CCGGTGTTCC TGTCCGAGGA CGCCAAGGAG GGGCCGCGTG CGTTCAAGGA GAAGCGCGCA CCGAACTTCC AGATGAAG

© 2021 Seattle Children's Research Institute. All rights reserved.